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Abstract
Airway epithelial cells have been demonstrated to be accessory antigen presentation cells (APC) capable of activating T cells
and may play an important role in the development of allergic airway inflammation of asthma. In asthmatic airways, loss of
expression of the adhesion molecule integrin b4 (ITGB4) and an increase in Th2 inflammation bias has been observed in our
previous study. Given that ITGB4 is engaged in multiple signaling pathways, we studied whether disruption of ITGB4-
mediated cell adhesion may contribute to the adaptive immune response of epithelial cells, including their ability to present
antigens, induce the activate and differentiate of T cells. We silenced ITGB4 expression in bronchial epithelial cells with an
effective siRNA vector and studied the effects of ITGB4 silencing on the antigen presentation ability of airway epithelial cells.
T cell proliferation and cytokine production was investigated after co-culturing with ITGB4-silenced epithelial cells. Surface
expression of B7 homologs and the major histocompatibility complex (MHC) class II was also detected after ITGB4 was
silenced. Our results demonstrated that silencing of ITGB4 resulted in impaired antigen presentation processes and
suppressed T cell proliferation. Meanwhile, decrease in Th1 cytokine production and increase in Th17 cytokine production
was induced after co-culturing with ITGB4-silenced epithelial cells. Moreover, HLA-DR was decreased and the B7 homologs
expression was different after ITGB4 silencing. Overall, this study suggested that downregulation of ITGB4 expression in
airway epithelial cells could impair the antigen presentation ability of these cells, which further regulate airway
inflammation reaction in allergic asthma.
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Introduction
Atopic asthma is characterized by Th2-mediated inflammation
and typical impaired airway epithelial cells. In the airways of
asthma patients, exposure to allergens induces an increase in Th2
cell infiltration and Th2 cytokine expression [1]. Activated T cells
have been implicated in asthma and physically interact with
epithelial cells in the airway [2,3]. As the first barrier to
environmental pollutants and allergic stimuli, airway epithelial
cells play an important role in driving the activation and
differentiation of T cells in respiratory allergies [4,5]. Several
studies have verified that airway epithelial cells can act as effective
immune regulatory cells the production of a series of cytokines and
chemokines [6,7]. Recent studies further found that airway
epithelial cells can affect the outcome of T cells immune responses
by acting as antigen presentation cells (APCs). Effective antigen
presentation by APCs is an important way to activate and induce
the activation and proliferation of T cells [8,9]. Airway epithelial
cells compose the first cell layer of the respiratory airway and thus
are best positioned to identify antigens. Consequently, antigen
presentation by airway epithelial cells may be an effective and
important way to guard the airway against harmful antigens and
to regulate the local T cell immune inflammation in the airway
[10].
Inflammation cells infiltration and Th2 biased inflammation are
the major phenotypes on the airway of asthma patients [1].
However, the specific mechanism underlying these features is still
unclear. Airway epithelial cells from asthma patients often show
significant structural damage and loss of functional homeostasis
[11,12,13]. Loss of structural adhesion could enhance the access of
inhaled allergens to underlying APCs. Our previous work
demonstrated that structural adhesion molecule integrin b4
(ITGB4) is downregulated in asthma airway epithelial cells. As
the first cell barrier to outer allergens, the airway epithelial cells
showed a decreased wound repair and anti-oxidation ability after
ITGB4 was downregulated [14,15]. ITGB4 is an important
adhesion molecule that mediates the anchoring of airway epithelial
cells to the basal membrane. Given that ITGB4 is known to
engage in multiple signaling pathways that may influence many
physiological functions of airway epithelial cells [16,17], we
questioned whether downregulation of ITGB4 enhanced the
invasion of inhaled allergens and regulated the local T cell
immune inflammation through antigen presentation process. In
this study, ITGB4 was silenced by a specific siRNA virus vector.
We observed that downregulation of ITGB4 is associated with
blocked antigen presentation ability, decreased MHC class II
(HLA-DR) expression and altered B7 homologs expression on
airway epithelial cells. Furthermore, decreased T cell proliferation
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e32060and differential cytokine production was induced after co-culturing
with ITGB4-silenced epithelial cells.
Materials and Methods
Cell culture
The immortalized human bronchial epithelial cell line
16HBE14o- (kind gift of Prof. Gruenert of the University of
California, San Francisco) was maintained at 37uCi n5 %C O 2 in
a mixture of DMEM:F12 (1:1) media supplemented with 100 U/
ml penicillin, 100 U/ml streptomycin and 10% heat-inactivated
fetal bovine serum (FBS).
ITGB4-specific siRNA vector construction and transfection
The effective ITGB4 siRNA and control siRNA were annealed
and ligated into the new pGCSIL-PUR vector to create an ITGB4
siRNA expression vector and a control expression vector
(Genechem, China, Shanghai) [14]. All plasmids were sequenced
to confirm that they were correct. Then, the ITGB4 silencing
vector (ITGB4 siRNA vector) and nonsense siRNA vector (control
vector) were packaged into recombinant lentivirus vectors using
Lentivector Expression Systems (GeneChem, Shanghai, China)
and titered to 10
9 TU/mL.
Before transfection, 16HBE14o- cells were plated in 24-well
plates (2610
4 cells/well) overnight. The lentiviruses were diluted
in 0.2 mL (10
8 TU/mL) of complete medium containing
polybrene (8 mg/mL) and added to the cells for 1 h at 37uC,
followed by incubation in 0.3 mL of freshly prepared polybrene-
DMEM/F12 for another 24 h. Then this media was replaced with
fresh DMEM/F12 medium, and the cells were cultured for 48 h.
Under our experimental condition, to silence ITGB4, 16HBE14o-
was infected with ITGB4-specific siRNA Lentivector vector by
addition of lentivirus into the cell culture at a MOI of 5. In this
study, the transfection was repeated for each experiment.
Real-time PCR detection after vector transfection
Real time PCR was used to detect ITGB4 mRNA expression
after transfection. The sequences of the primers and taq man
probes used are as follows: ITGB4 forward: 59-CAC CGC GTG
CTA AGC ACAT-39, ITGB4 reverse: 39 -TGT GGT CGA GTG
TGA GTG TTC TG-59, taqman probe: fam+ACC CTC ACA
CGG GAC TAC AAC TCA CTG+tamra, GAPDH forward: 59 -
CCA CTC CTC CAC CTT TGA C-39, GAPDH reverse: 39-
ACC CTG TTG CTG TAG CCA-59 and taqman probe:
fam+TTG CCC TCA ACG ACC ACT TTGT+tamra. Seventy
two hours after transfection, total RNA (1 mg) purified from
different vector transfected groups was reverse transcribed into
cDNA using AMV reverse transcriptase (Qiagen, Vento, Nether-
lands) with an RNase inhibitor and oligo d(T) primer at 40uC for
50 minutes followed by heating at 90uC for 5 minutes. Then, 1 ml
of the reverse-transcript was added to a 30 ml PCR mixture for
40 cycles. Each cycle included 93uC for 30 s and 54uC for 60 s
and used Taq polymerase. Negative controls consisted of an equal
volume of water substituted for the volume of RNA in the RT
reaction. Normalization of mRNA expression data for sample-to-
sample variability in RNA input, RNA quality, and reverse
transcription efficiency was achieved by comparing the copy
numbers of target mRNAs with that of human GAPDH.
Western blot analysis after vector transfection
Seventy two hours after transfection, proteins from parental
16HBE14o- cells, control vector transfected cells, and ITGB4
siRNA viral vector transfected cells were separated by SDS-PAGE
and then transferred to polyvinylidene difluoride membranes
(Millipore, Bedford, MA). Blots were blocked and then probed
with antibodies against ITGB4 (1:1,000 dilution; Santa Cruz, CA,
USA) and GAPDH (1:5,000 dilution; Sigma, St. Louis, MO,
USA). After washing, the blots were incubated with horseradish
peroxidase–conjugated secondary antibodies and visualized by
super ECL detection reagent (Applygen, China, Beijing).
Antigen presentation detection
To acquire vivid and precise results, the antigen presentation
process in 16HBE14o- cells was analyzed by laser confocal
microscopy and flow cytometry separately [8].
For laser confocal microscopy detection, 16HBE14o- cells from
control group and ITGB4 silence group that adhere to glass
coverslips were incubated with the FITC-labeled OVA for various
periods; then they were rinsed in PBS and fixed with 3:1
methanolacetic acid for 5 min at 4uC. Then, fixed cells were
blocked with PBS containing 5% goat serum and 0.2% Triton X-
100 (Sigma) for 15 min before incubation with the anti-HLA-DR
antibody for 1 h. The cells were rinsed three times in PBS before
incubation with Dylight 549 (red) labeled conjugated Ig (Thermo
Scientific, Waltham, MA). The coverslips containing 16HBE14o-
cells were then rinsed in PBS three times and mounted with
Immun-mount (Shandon, Pittsburgh, PA) before they were viewed
with a laser confocal microscope (Fluorvert, Leica, Deerfield, IL)
at a step position of 1 mm on the x-y or x-z axis. Three observers
routinely examined 10 separate fields. Mean fluorescence
intensities of the internalized FITC-labeled OVA in the cells of
the entire field examined were determined with Leica Fluorvert
Laser confocal microscope using the image software package.
For flow cytometry detection, cells from different groups were
incubated with the FITC-labeled OVA for various periods; then
they were rinsed in PBS and collected with PBS containing 1%
FBS and 0.01% NaN3. The FITC fluorescence intensity of
16HBE14o- cells was analyzed by FACS Calibur flow cytometer
(Becton Dickinson, Mountainview, CA).
Lymphocyte proliferation assay
Peripheral blood was obtained from healthy volunteers
following the approval for the use of human tissues was granted
by the Ethical Committee of Central South University after
obtaining written informed consent from individual donors.
Heparinized venous blood was collected and diluted 1:3 with
PBS, layered on a Ficoll-Hypaque density gradient, and
centrifuged for 30 min at 1,400 rpm. Peripheral blood T
lymphocytes were collected from the interface and washed three
times with PBS. Cells were resuspended in RPMI 1640, and cell
density was adjusted to 5x10
6 cells/ml. CD4
+ T cells were purified
from Peripheral blood T lymphocytes by negative selection (Stem-
Cell, Vancouver, Canada). Then, 10
5 CD4
+ T cells were
cocultured with 10
5 freshly isolated 16HBE14o- cells in triplicate
round-bottom plates in 0.2 ml serum-free culture medium at 37uC
in a 5% CO2 incubator for 3 days with OVA (0.1 mg/ml). To
avoid HLA-class II allele unmatching during the co-culturing, all
the CD4
+ T cells from different donors was selected to be matched
under our experimental condition. In some experiments ITGB4-
silenced 16HBE14o- cells were used to coculture with CD4
+ T
cells. T cells proliferation was assessed by 5-bromo-2-deoxyuridine
(BrdU) incorporation assay and carboxyfluorescein diacetate-
succinimidyl ester (CFDA-SE) labeling separately.
For CFDA-SE labeling (CellTraceTM CFSE Cell Proliferation
Kit, Invitrogen, Eugene, OR, USA), the T cell suspension was
washed three times with PBS and finally resuspended in culture
medium. T cells were resuspended in PBS at 5610
6/ml for
staining. CFSE in the form of a 5 mM stock solution in DMSO
Integrin b4 Airway Epithelial Cell Present Antigen
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The CSFE-labeled cells were cocultured with control transfected
cells or ITGB4-silenced cells. After 5 days of coculture, the
proliferation of CD4
+ T cells was detected by assessing CFSE
fluorescence intensity.
For BrdU incorporation (Roche Applied Science, Mannheim,
Germany), T cells proliferation was evaluated by measuring BrdU
incorporation in a colorimetric assay according to the manufac-
turer’s instructions. The assay was performed according to the
instructions of the manufacturer (Roche Applied Science,
Mannheim, Germany). Absorbance values were measured at
450 nm using an ELISA reader (Tecan, Crailsheim, Germany).
The blank corresponded to 100 ml of culture medium without
BrdU. T-cell proliferation was evaluated by measuring BrdU
incorporation from the first day to the fifth day after coculture.
ELISA
The levels of the cytokines IFN-gamma, IL-4 and IL-17 in the
cocultured supernatants of 16HBE14o- cells and T cells were
determined by ELISA according to the manufacturer’s protocols
(Sigma, St. Louis, MO, USA).
Flow cytometry Assay
To detect the B7 homolog and HLA-DR expression on
16HBE14o- cells after ITGB4 was silenced, the monoclonal
antibodies used for flow cytometry were as follows: monoclonal
antibody anti-human B7-H1 (Ebioscience, San Diego, CA), B7-H2
(Ebioscience, San Diego, CA), B7-H3 (Ebioscience, San Diego,
CA), B7-DC (Ebioscience, San Diego, CA), HLA-DR
(Ebioscience, San Diego, CA). Typically, 5–10610
4 cells from
different groups were incubated in 60 ml of PBS/0.2% BSA/0.1%
NaN3 containing saturating concentrations of each monoclonal
antibody on ice for 30 min. The cells were then washed and
resuspended in the buffer, and immediately analyzed with a FACS
Calibur flow cytometer.
In addition, the staining of the intracellular cytokines after T cell
activation was also measured by flow cytometry. Briefly, T cells
previously co-cultured with control vector transfected 16HBE14o-
cells or with ITGB4 silenced 16HBE14o- cells were restimulated
for 4 h at 37uC in 10%CO2 with phorbol ester (50 ng/ml; Sigma),
ionomycin (1 mg/ml; Sigma) and GolgiStop (1 ml per 1.5 ml; BD
Bioscience).The Cytofix/Cytoperm buffer set (BD) was used for
intracellular staining. Cells were fixed and treated with permea-
bilization buffer according to the manufacturer’s instructions and
stained with corresponding fluorescence-labeled antibodies (BD).
Acquisition was performed with CellQuest software on a FACS
Caliber flow cytometry
Statistical analysis
All experiments were run at least five times. All data are
presented as the mean 6standard error of the mean (SEM). For all
values, the differences were considered significant when *P,0.05
or **P,0.01. The unpaired t test was used for comparison
between two groups. Comparisons of the differences between the
ITGB4-silenced group and control groups were performed by
means of one-way ANOVA, followed by Dunnett’s or LSD’s post-
hoc test.
Results
ITGB4 mRNA and protein expression was effectively
silenced by ITGB4 siRNA lentivirus vector
The silencing efficiency on ITGB4 mRNA and protein
expression was detected by real time PCR and western blotting.
The ITGB4 siRNA lentivirus vector and control lentivirus vector
were prepared and transfected into 16HBE14o- cells. Three days
after transfection, real time PCR results showed that ITGB4
mRNA was inhibited obviously (**P,0.01, n=6) (Figure 1.A).
Meanwhile, the ITGB4 siRNA virus vector could inhibit ITGB4
protein expression significantly (P=0.0006, n=6, ANOVA)
(Figure 1.B). More than 75% ITGB4 protein expression was
Figure 1. Silencing efficiency was detected after ITGB4 siRNA-containing lentivirus was transfected. The effective ITGB4 siRNA lentivirus
vector and control nonsense siRNA lentivirus vector were prepared and transfected into 16HBE14o- cells. (A) 72 h after lentivirus vector transfection,
ITGB4 mRNA expression was detected by real time PCR. (B) Western blot analysis was used to detect ITGB4 protein expression 72 h after tansfection.
(C) Quantification of western blot normalized to the level of GAPDH in Figure 1A.
doi:10.1371/journal.pone.0032060.g001
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virus vector (Figure 1.C). While compared with the control siRNA
vector, there was no significant influence on the ITGB4 protein
expression (P.0.5, n=6, ANOVA) (Figure 1.C). We observed no
obvious changes in cell confluence or morphology.
Colocalization of Ag with HLA–DR
As respiratory epithelial cells express MHC class II antigens,
and in our study induced OVA-specific T-cell proliferation in
accord with previously reported data, we wanted to determine
whether the endocytosed OVA followed a class II trafficking
pattern. We colocalized Dylight 549-labeled anti-HLA–DR
antibody with FITC-labeled OVA (red+green=yellow) in
16HBE14o- cells from different groups, using laser confocal
microscopy (Figure 2). Colocalization occurred optimally 90 min
after OVA pulsing which was diminished 120 min later. These
results demonstrate that OVA uptake by 16HBE14o- cells was an
active process and was not due to passive diffusion. In addition,
FITC labeled OVA, is endocytosed by 16HBE14o- and follows a
class II processing pathway.
FITC-OVA trafficking ability was downregulated in ITGB4-
silenced 16HBE14o- cells
By dynamic recording of the OVA fluorescence intensity at
different time points, we observed the antigen presentation ability
of 16HBE14o- cells. After FITC-labeled OVA was plused with the
16HBE14o- cells, speckled green fluorescence signals could be
observed from 30 min. Then, the fluorescence signals increased at
60 min and maximally expressed at 90 min which persisted for up
to 120 min. For the ITGB4 silenced group, the uptake of FITC-
labeled OVA was decreased obviously (Figure 3.A). In contrast to
the conspicuous punctuate staining observed after pulsing with
FITC-labeled OVA in control transfected cells, there is a
noticeable decrease of fluorescence staining intensity at the same
time points in the ITGB4-silenced cells by laser confocal
microscopy detection(**P,0.01, n=6) (Figure 3.B).
To better quantify the differences in OVA uptake after ITGB4
silencing, the mean fluorescence intensity within bronchial
epithelial cells at all time points was instantaneously assessed by
flow cytometry (Figure 3.C). The 16HBE14o- cells were pulsed
with FITC-labeled OVA and collected at all tested time points to
detect by flow cytometry. The flow cytometry results demonstrated
that the mean fluorescence intensity of 16HBE14o- cells was
degraded significantly when ITGB4 was silenced. Therefore, the
above results indicated that the antigen uptake ability in
16HBE14o- cells was downregulated when ITGB4 was silenced.
Comparison of T cell proliferation induced by control
16HBE14o- cells and ITGB4-silenced 16HBE14o- cells
To further investigate the interaction between airway epithelial
cells and T cells and to better define the role of 16HBE14o- cells in
antigen presentation, we used CFSE staining to assess proliferation
of T cells after 16HBE14o- cells and T cells coculture.
Experiments were performed using seven different specimens,
and the results were examined to ensure that patient variability did
not affect the results. After 3 days of coculture, proliferating T cells
represented 10–30% of all T cells. In contrast, nonactivated T cells
(T cells cultured alone or T cells cultured with OVA) did not
divide. Analysis of the CFSE staining showed that the majority of
these proliferating cells undergone about three divisions. Percent-
age of dividing cells is shown for different coculture groups. Our
results showed that the ratio of proliferated T cell is obviously
decreased in ITGB4 knockdown group compared with control
group (20.86%62.51% vs.32.22%63.12%,**P,0.01, n=6)
(Figure 4.A). By recording the percentage of dividing cells, we
also found that there is a distinguished difference for the ratio in
two division cell group (19.57%62.72% vs. 11.71%63.45%,
**P,0.01, n=6) and three division cell group (8.45%63.21% vs
5.69%62.81%, **P,0.01, n=6) between the control coculture
Figure 2. Colocalization of HLA-DR with endocyosed OVA in
respiratory epithelial cells. 16HBE14o- cells from different groups
were pulsed with FITC-labeled OVA for 0–120 min, fixed, permeabilized,
and stained with Dylight 549-labeled anti-HLA-DR antibodies. Cells were
analyzed by confocal microscopy. Yellow staining (red+green) indicates
colocalization. Results are representative of 1 experiment repeated 3
times.
doi:10.1371/journal.pone.0032060.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e32060Figure 3. Antigen trafficking was surveyed after ITGB4 was silenced. (A) Control transfected 16HBE14o- cells and ITGB4-silenced cells were
grown on coverslips, pulsed with FITC-labeled OVA, washed at different time points, and analyzed through laser confocal microscopy. (B)
Quantification of staining intensity in figure 3A. (C) Representative histogranms showing the fluorescence intensity of 16HBE14o- cells from different
groups after plused with FITC-labeled OVA. The antigen trafficking ability was determined according to flow cytometry detection at all time points.
doi:10.1371/journal.pone.0032060.g003
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time, the proliferation of T cells was detected by BrdU-
incorporation ELISA. Compared with control group, the number
of T cells decreased significantly from the first day to the fifth day
after coculture in the ITGB4 silenced group (**P,0.01, n=10)
(Figure 4.B). In addition, the suppression effect became more and
more obvious along with the days of coclture.
Cytokines produced by T cells after stimulation with
ITGB4-silenced 16HBE14o- cells
We also determined cytokine (IFN-gamma, IL-4 and IL-17)
production as measured by ELISA in supernatant from
16HBE14o- cells and T cells coculture for 3 days. IFN-gamma,
IL-4 and IL-17 are typical T cells cytokine that can be used to
represent different T cell derivation subpopulation after T cells
proliferation. Our results showed that T cells cocultured with
16HBE14o- cells produced IFN-gamma and IL-17, but little IL-4.
After ITGB4 silencing, the production of IFN-gamma was
decreased (**P,0.01, n=10, Figure 5.A), IL-17 was increased
(**P,0.01, n=10, Figure 5.C). But there was no obvious
difference in IL-4 production (P.0.5, Figure 5.B).
To characterize the source of cytokine production at the cellular
level, we simultaneously detect intracellular cytokine staining after
couture (Figure 6.A). As expected, in the ITGB4 silencing
coculture group, IFN-gamma was decreased (48.662.9 vs.
29.264.3, P,0.01, n=6), IL-17 was increased (16.362.1 vs.
36.863.1, **P,0.01, n=6). Also, we found little production of IL-
Figure 4. T cell proliferation was observed after coculturing T cells with control transfected 16HBE14o- cells or ITGB4-silenced cells.
(A) On the basis of decreased CSFE staining, T cell proliferation are shown as percentage of proliferating cells, and are representative of one
experiment repeated six times. Percentage of dividing cells (cells that have undergone 1 division) is shown for control silenced 16HBE14o- cells +T
cells and ITGB4 silenced 16HBE14o- cells +T cells cocultures. Proportion of original population induced to divide after stimulation was determined by
measuring the number of events in each cell division. (B) Meanwhile, T cell proliferation was assessed by a BrdU incorporation assay after coculture.
The data are expressed as the mean (6SEM) values of the specific absorbance from 10 independent experiments.
doi:10.1371/journal.pone.0032060.g004
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(Figure 6.B).
Surface protein expression of B7 homolog and HLA-DR
proteins on 16HBE14o- cells after ITGB4 silencing
We set out to extend previous studies to determine whether the
expression of B7 homologs and HLA-DR on 16HBE14o- cells was
altered after ITGB4 silencing (Figure 7.A). Our results showed that
16HBE14o- cells displayed spontaneously surface expression of
B7H1, B7H2, B7H3 and B7DC. And the relative order of B7
homolog family surface expression: B7-H3.B7-H1 » B7-DC ,
B7-H2. After ITGB4 was silenced, the expression of B7H1
(21.662.4 vs 53.7%62.9, **P,0.01, n=6) and B7DC (17.561.5
vs 33.762.2, **P,0.01, n=6) both increased obviously. But,
ITGB4 silencing has no effect on the expression of B7H2 (1961.5
vs 17.961.2, P.0.1, n=6) and B7H3 (7462.8 vs 7163.2, P.0.1,
n=6). As for HLA-DR, our results showed that the expression of
HLA-DR was decreased after ITGB4 silencing (55.361.7 vs
35.963.4, **P,0.01, n=6) (Figure 7.B).
Discussion
Allergy immune disorder diseases like asthma are characterized
by Th2-mediated inflammation and structural disruption of
airway epithelia cells. In these diseases, an increase in Th2 cell
infiltration and Th2 cytokine expression is induced after allergy
exposure [1]. However, the intrinsic molecular mechanism
underlying this Th2 inflammation bias is not fully understood.
Previous studies demonstrate that airway epithelial cells engage in
the initiation and regulation of inflammation and immune
responses through production of cytokines and chemokines and
others [18,19]. Recent studies further showed that bronchial
epithelial cells are capable of antigen presentation and thus can
regulate the local airway immune cells and inflammation reactions
[8,9]. Especially, T cells can be effectively activated by airway
epithelial cells through antigen presentation after allergen
exposure on the airway.
The airway epithelial barrier is often disrupted in asthma
patients, with evidence for shedding of airway epithelial cells and
disparity expression of genes. Our previous study demonstrated
that ITGB4 is downregulated in asthma airway epithelial cells,
which may result in decreased wound repair and anti-oxidation
ability [11,12]. In this current study, our results demonstrated for
the first time that downregulation of ITGB4 blocked the process of
antigen trafficking which indicated that the ITGB4-silenced cells
are damaged cells and cannot maintain the normal function of
monitoring outer allergens and present the foreign antigen to local
T cells. As effective APCs, the recognition and uptake of outside
allergens is the first step for the local immune homeostasis [20].
Furthermore, the uptake and presentation of antigen by APCs has
a close relationship to the activation and differentiation of local T
cells [1,21]. Therefore, we examined the influence of ITGB4
silencing on local airway T cells inflammation. By CFSE staining
and BrdU-incorporation assay, we found that the proliferation of
T cells was inhibited after coculturing with ITGB4-silenced
16HBE14o- cells. At the same time, T cell-derived IFN-gamma
was reduced; IL-17 was increased by ELISA detection and
intercellular cytokine staining. It is well known that Th2 cells
orchestrate allergy-induced asthmatic inflammatory responses,
and the main immune abnormalities are caused by Th2 cytokines,
such as IL-4 and IL-5, which induce eosinophil infiltration and
airway hyperresponsiveness [4,7]. On the contrary, IFN-gamma, a
Th1 cytokine, reduces airway inflammation and airway hyper-
esponsiveness in asthma models and clinical traits [22,23]. Besides,
Th17 cells are a recently described effector CD4
+ T cell subset
characterized by the production of IL-17, which have been
implicated in the pathogenesis of several autoimmune diseases
[24]. IL-17 promotes neutrophil production and chemotaxis via
multiple factors which might play a prominent role in the
pathogenesis of asthma [25,26]. Increasing amounts of papers
suggested that airway local immune inflammation is a conse-
quence of the actions of many cells and signaling events [4,21,27].
Antigen presentation by airway epithelial cells is an effective way
Figure 5. Cytokine concentrations in supernatants of the
16HBE14o- cells and T cells cocultures were quantified by
ELISA. The graphs show mean (6SEM) values from a representative
experiment of six independent experiments. The content of (A) IFN-
gamma, (B) IL-4 and (C) IL-17 was performed respectively.
doi:10.1371/journal.pone.0032060.g005
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presentation after ITGB4 silencing would have a close relationship
to the asthma airway inflammation. Thus, our results verified the
influence of Th2 inflammation induction by ITGB4 low
expression on asthma airway epithelial cells. It provided one
possible pathway which is correlated to T cell activation and Th2
inflammation bias in the asthma airway mucosa.
Antigen presenting cells are charactered in part by the presence
of specific cell surface immune molecules that allow interaction
with the T-cell receptor complex. The most well known cell
surface protein is the MHC II molecules. We evaluate HLA-DR
expression after ITGB4 silencing and find that HLA-DR
expression was depressed after ITGB4 was silenced. HLA-DR
has attracted considerable interest due to its role in antigen
presentation [28]. More importantly, maturation of dendritic cells
also results in an increase in HLA-DR expression and the
expression of HLA-DR is tightly regulated by inflammatory
cytokines[29]. As HLA-DR is a key protein for antigen
presentation processes, our results indicated that the decreased
antigen presentation ability after ITGB4 silencing partly result
from the depressed expression of HLA-DR.
To further explore the possible mechanism for the altered T
cells derivation after ITGB4 silence. We investigated the B7
homologs expression after ITGB4 silencing. The flow cytometry
results showed that both B7H1 and B7DC was induced after
ITGB4 silencing, but no obvious difference was detected for B7H2
and B7H3. It is well known that the optimal activation of T cells
requires both costimulation [30] and TCR (T cell receptor)
engagement [8,9]. Antigen presentation in the absence of
costimulation may lead to T cell anergy. When the antigen-
specific T cells recognize the anigen peptide complex, the
following T cell responses are critically affected by the simulta-
neous signaling operated through B7 costimulatory molecules.
Both B7-H2 and B7-H3 are thought to be positive costimulatory
ligands in that engagement results in activation of T cell function.
Engagement of B7-H2 results in activation of T-helper memory
cells with a bias toward Th2 cytokine production, such as IL-4 and
IL-13 [31]. Engagement B7-H3 ligands results in proliferation T
cells, a bias toward Th1 cytokine production, and primary
cytotoxic T cell activation[32]. B7H1 and B7DC are ligands for
programmed death-1 (PD-1), which is expressed on activated T
cells. Colligation of PD-1 and the T cell receptor leads to the rapid
phosphorylation of SHP-2, a phosphatase that inhibited the T cell
activation [33,34]. Given that the PD-1 ligation delivered an
inhibitory signal to T cell activity, the upregulation of B7H1 and
B7DC after ITGB4 silencing may be associated with T cells
proliferation and derivation after allergy exposure. We also
blocked the B7H1 and B7DC action with neutralizing antibodies
to evaluate the impact on T cell proliferation. The results show
that the T cell proliferation was promoted, which are consistent
with the previous studies [33,34]. However, the internal regulatory
mechanisms between the T cells inflammation derivation and the
B7 family expression are still unclear and more work is needed to
explain them.
In light of the data in this work, we find that airway epithelial
cells, which constitutively express B7 costimulatory molecules, can
Figure 6. Flow cytometry analysis of the intracellular expression of IFN-gamma, IL-4 and IL-17 at CD4
+ T cells after coculturing. (A)
CD4
+ T cells from different coculturing groups were stained with specific antibodies to IFN-gamma, IL-4 and IL-17 as described in materials and
methods. The histograms shown are from a representative results of six independent experiments are shown. (B) The mean relative fluorescence
intensity of intracellular cytokine was quantified after ITGB4 silencing.
doi:10.1371/journal.pone.0032060.g006
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airways by antigen presentation processes. In addition, silencing of
ITGB4 in asthma airway epithelial cells led to impaired antigen
presentation. In turn, the proliferation of T cells was inhibited, and
production of IFN-gamma was decreased, IL-17 was increased,
which may relate to Th2 inflammation bias and neutrophil
production on asthma airway. These data partly elucidate the role
that epithelial cells play in the inflammation phenomenon of
asthma and bring some new useful clues to our understanding of
the pathogenesis of immune surveillance and inflammation
responses in asthma.
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